Dr. B.M. Sharma M. K. Singh MBBS. MO. (Micro) MLE (Lucknow): Regd. No. 13258. (i Patient Name Miss. Jaya Vishvakarma Reporting Date 31-01-2023 Age (Y-M-D) 2-0-0 Sex -F Sample In House | Ref By Dr Snigdha Singh DGO | Address ) HAEMATOLOGY INVESTIGATION RESULT UNIT: NORMAL VALUE TOTAL W.B,C, COUNT: 5900 fou m.m. 5000 to 10000 DIFFERENCIAL W.B.C. COUNT Polymorphs. 44 % 4010 75 Lymphocytes 53 % 20to 45 Eosnophills 02 % 1to8 Monocytes ot % 00- 02 Basophils 00 % Oto1 Immature Cell 00 % ESR ESR (App.) 28 mm PCV 34 % ESR (Corr.) 16 mm Me 0-10, F: 0-15 (WINTROBE- M 0-10 F 0-15) Mx, Test (10 TUI0.1 mI P.P.D. Used) Incoulation. SmmX5mm Induration 25 mmx mm 25 mm Results PORIWVENEGHINE BIOCHEMISTRY INVESTIGATION, RESULT UNIT NORMAL VALUE Plasma Glucose R 76.0 mg/dl < 160 Not: Nt Media ea pupse109 2044 ene, YS: pouty (aw) eeu eas,(ous Susur ) n ninwas Frovren nog use,09 8g ssa9tioauan tas ewsbus0 srw ze ivenoinnsin vave sie fapauojoy ‘olwoneg= Hoday Jo pug “sapuas ay} Aq uawiidads pies ay) Jo uoHessueB quiod au 12 ino payeo useq sey UONeOYIJEA YONs pue ysanbol jsayiaulejuod ayy UO pa|aqe| se paluap! Jo psweu yusyed 84) 0} sBudjaq uawioads ayy yey) pawnsaid s} “SuoHe90] T]A-UOU WO4} pa}daljoo 40 panlaoas suaWI9ads UO Pswwoyed jse} 104 quanjed ay) Jo snje}s jeoUNJo 1270) ay) pue sBulpuy Aroye10ge] sayjo Jo }xa]U0D ay} ul AJUO pajasduayu! aq pinoys syinsas Aessy : 3]0N VITO : pours Twy/Bu L'€z - Ey ssseeA 1Z- EL TwyBu z'g1 - S*€ :sHe2A ZL - O} qw/Bu eS - Le: iva, g- p Twy6u LL - Le: sua, g-z (]ewW24) suasprya TWw/BU Sh - pg :sieaA yz - 71 wy6u SEL - 2'¢ :sueag gy) - OL W/E ORL - Sb: siEa, g- p TWybu g'9z- gre: sea, g-z (21eW) suaspry9 Twy/Bu 224 - 17 ‘SaleW yn; TwyBu 02 - gy: lesnedousys Tee TWw/6u S802 - 16 : usuBa1g Wu 262 - 8°2 :ueuBarg oN, sajeway ynpy 1wy6u ge'zy 9249198 Aq Pasidsuy “AyjenGNe Wegee eS 2 UWI,a Test Report Name : MISS JAYA VISHWAKARMA, Registration Number: UPPDC116/HQ663167/1 AgelSex —: 22 YrsiFEMALE Sample Drawn On: 31-Jan-2023 00:00 Hrs Patient 1D ‘Sample Received On: 02-Feb-2023 04:26 Hrs Referred by: Dr.Snigdha Singh Reported On 02-Feb-2023 08:32 Hrs Client ode: UPPDC116DP Roport Printed On: 02-Feb-2023 09:59 Hrs Client Name: Singh Collection Centre, Varanasi sip 15682177 Sample Type : SERUM :Mc232723000264409P ULR CLINICAL BIOCHEMISTRY RA Sls PRRs Estradiol(eE2) 18.23 pgiml. Males: Up to 39.8 pgimL Menstruating females (by day in cycle relative to LH peak) Follicular phase (-12 to -4 days): 19.5 - 144.2 pgimL Mid cycle (-3 to +2 days): 63.9 - 356.7 pgimL. Luteal phase (+4 fo #12 days): 55.8 - 214.2 pg/mL. Post-menopausal females (untreated): Up to 32.2 pglm ‘Method : CLIA fete: Assay resulls should be interpreted only in the context of other laboratory findings and the total clinical satus ofthe patient. Forcast performed on specimens received or collected from nor-VL.fcation, its presumed thatthe specimen belongs to the Fon aetna cenlifed as labeled on the contsinerfest request and such verification has been carried out at the point ‘generation of the said specimen by the sender. End of Report‘Nam : MISS JAYA VISHWAKARMA, AgelSex 22 YrsIFEMALE. Patient ID Referred by: Dr-Snigdha Singh Client Code: UPPDO1160P Client Name: Singh Collection Centre, Varanasi Sample Type : SERUM CLINICAL = Tae ‘TSH_Thyroid Stimulating Hormone (Ulta) Method : CLIA Note : Assay results should be i terpreted only in the context of other lab For test performed on specimens received of collected from non-VLL Test Report Registration Number Sample Drawn On ‘Sample Received On upPOCt terHace316714 31-Jan-2023 00:00 Hrs 02-Feb-2023 04:26 Hrs Reported On 02-Feb-2023 08:32 Hrs Report Printed On: 02-Feb-2023 09:59 Hrs ID 215682177 ULR :Mc232723000264409P IC ISTRY 2.57 IU/ML Ag Zi eca -20 yeas: 07-64 Bint Stee anti apie ‘55 - 87 years: 0.5 - 8.9 [U/mL mone Ast Trimester: 0.24 - 2.99 [U/mL 2nd Trimester: 0.46 - 2.95 |U/mL ‘3rd Trimester: 0.43 - 2.78 [U/mL Peelas Range Cort Boca 29 192 ui Tozdeyerod assume 2aaarnoy seein 2-20weeke 17 ast ratory findings and the total clinical status of the patient, locations, itis presumed that the specimen belongs to the patient named or identified as labeled on the containetitest request and suct generation ofthe said specimen by the sender ‘Test Marked with # are referred to our accredited Partner Lab. h verification has been carried out at the point End of Report ———